Loading viewer...
investor_presentation
Format: PDF investor_presentation
Second Quarter 2022 Earnings Call Presentation August 4, 2022
Earnings Call Presentation
This presentation (and oralstatements regarding thesubject matter ofthispresentation) includes forward -looking statements intended to
qualify under the“safe harbor” from liability established bythePrivate Securities Litigation Reform Actof1995 .These forward -looking
statements include anystatements reflecting Quanta's expectations, intentions, strategies, assumptions, plans orbeliefs about future
events orperformance orthat donotsolely relate tohistorical orcurrent facts .Forward -looking statements involve certain risks,
uncertainties andassumptions thataredifficult topredict orbeyond Quanta's control, andactual results may differ materially from those
expected, implied orforecasted byourforward -looking statements duetoinaccurate assumptions andknown andunknown risks and
uncertainties .Foradditional information concerning some oftherisks, uncertainties, assumptions andother factors thatcould affect our
forward -looking statements, please refer toQuanta’s Annual Report onForm 10-Kfortheyear ended December 31,2021 ,Quarterly
Reports onForm 10-Qforthequarters ended March 31,2022 and June 30,2022 (when filed) and other documents filed with the
Securities andExchange Commission, which areavailable onourwebsite (www .quantaservices .com), aswellastherisks, uncertainties
and assumptions identified inthispresentation .Investors and analysts should notplace undue reliance onQuanta’s forward -looking
statements, which arecurrent only asofthedate ofthispresentation .Quanta does notundertake andexpressly disclaims anyobligation
toupdate orrevise anyforward -looking statements toreflect events orcircumstances after thedate ofthispresentation orotherwise, and
Quanta expressly disclaims anywritten ororalstatements made byanythird party regarding thesubject matter ofthispresentation .
Certain information may beprovided inthispresentation thatincludes financial measurements thatarenotrequired by,orpresented in
accordance with, generally accepted accounting principles (GAAP) .These non-GAAP financial measures should notbeconsidered as
alternatives toGAAP financial measures, such asnetincome attributable tocommon stock andcash flowprovided byoperating activities,
andmay becalculated differently from, andtherefore may notbecomparable to,similarly titled measures used byother companies .Fora
reconciliation tothemost directly comparable GAAP financial measures, please refer totheaccompanying reconciliation tables .
The information contained inthisdocument has notbeen audited byany independent auditor .This presentation isprepared asa
convenience forsecurities analysts and investors andmay beuseful asareference tool.Quanta may elect tomodify theformat or
discontinue publication atanytime, without notice tosecurities analysts orinvestors .Notice to Investors
Call Participants and Agenda
President and Chief Executive Officer
Executive Vice President -Business Operations
Vice President, Investor Relations•Introduction and Forward -Looking
Statements Disclaimer
Preview truncated — download the full document for the complete content.
investor_presentation
55 Pages
investor_presentation
27 Pages
Adani
Sonoma Pharmaceuticals Investor Presentation April 2024
investor_presentationinvestor_presentation
32 Pages
Sonoma Pharmaceuticals, Inc.